Barely Significant
← all excerpts

One Target, Different Results: The Clinical Impact of Diagnostic Kit Choice in <i>BCR</i>::<i>ABL1</i> Testing for Chronic Myeloid Leukemia.

Diagnostics (Basel) · 2026 · PMC13408972 · PMID 42510079

Europe PMCDOI
1
hedged sentence
0.0010
closest p · 0.0× alpha
0.0010
boldest claim

The sentences

highly significantp < 0.001actually significant
This difference was highly significant according to both the paired Student’s t -test ( p < 0.001) and the Wilcoxon signed-rank test ( p < 0.001).

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.